Literature DB >> 20194580

Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.

I M Pomeroy1, E K Jordan, J A Frank, P M Matthews, M M Esiri.   

Abstract

BACKGROUND: Degenerative features, such as neuronal, glial, synaptic and axonal loss, have been identified in neocortical and other grey matter structures in patients with multiple sclerosis, but mechanisms for neurodegeneration are unclear. Cortical demyelinating lesions are a potential cause of this degeneration, but the pathological and clinical significance of these lesions is uncertain as they remain difficult to identify and study in vivo. In this study we aimed to describe and quantify cellular and subcellular pathology in the cortex of myelin oligodendrocyte glycoprotein-induced marmoset experimental autoimmune encephalomyelitis using quantitative immunohistochemical methods.
RESULTS: We found evidence of diffuse axonal damage occurring throughout cortical grey matter with evidence for synaptic loss and gliosis and a 13.6% decrease in neuronal size and occurring in deep cortical layers. Evidence of additional axonal damage and a 29.6-36.5% loss of oligodendrocytes was found in demyelinated cortical lesions. Leucocortical lesions also showed neuronal loss of 22.2% and a 15.8% increase in oligodendrocyte size.
CONCLUSIONS: The marmoset experimental autoimmune encephalomyelitis model, therefore, shows both focal and generalized neurodegeneration. The generalized changes cannot be directly related to focal lesions, suggesting that they are either a consequence of diffusible inflammatory factors or secondary to remote lesions acting through trans-synaptic or retrograde degeneration.

Entities:  

Mesh:

Year:  2010        PMID: 20194580      PMCID: PMC2874633          DOI: 10.1177/1352458509360362

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  36 in total

1.  Estimation of nuclear population from microtome sections.

Authors:  M ABERCROMBIE
Journal:  Anat Rec       Date:  1946-02

2.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

3.  Grey matter pathology in multiple sclerosis.

Authors:  Marco Vercellino; Federica Plano; Barbara Votta; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Journal:  J Neuropathol Exp Neurol       Date:  2005-12       Impact factor: 3.685

4.  Trophic factors attenuate nitric oxide mediated neuronal and axonal injury in vitro: roles and interactions of mitogen-activated protein kinase signalling pathways.

Authors:  Alastair Wilkins; Alastair Compston
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

5.  Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.

Authors:  Muriel Hobom; Maria K Storch; Robert Weissert; Katharina Maier; Anand Radhakrishnan; Birgit Kramer; Mathias Bähr; Ricarda Diem
Journal:  Brain Pathol       Date:  2004-04       Impact factor: 6.508

6.  Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

Authors:  Barbara Serafini; Barbara Rosicarelli; Roberta Magliozzi; Egidio Stigliano; Francesca Aloisi
Journal:  Brain Pathol       Date:  2004-04       Impact factor: 6.508

7.  Oligodendrocytes in the early course of multiple sclerosis.

Authors:  W Brück; M Schmied; G Suchanek; Y Brück; H Breitschopf; S Poser; S Piddlesden; H Lassmann
Journal:  Ann Neurol       Date:  1994-01       Impact factor: 10.422

8.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

9.  Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

Authors:  Jaume Sastre-Garriga; Gordon T Ingle; Declan T Chard; Mara Cercignani; Lluís Ramió-Torrentà; David H Miller; Alan J Thompson
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

10.  Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

Authors:  Ian M Pomeroy; Elaine K Jordan; Joseph A Frank; Paul M Matthews; Margaret M Esiri
Journal:  Neurosci Lett       Date:  2008-03-28       Impact factor: 3.046

View more
  8 in total

1.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

2.  The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous Diseases.

Authors:  Hyo-Jeong Han; Sarah J Powers; Kathleen L Gabrielson
Journal:  Toxicol Pathol       Date:  2022-05-10       Impact factor: 1.930

3.  The formation of inflammatory demyelinated lesions in cerebral white matter.

Authors:  Pietro Maggi; Sheila M Cummings Macri; María I Gaitán; Emily Leibovitch; Jillian E Wholer; Heather L Knight; Mary Ellis; Tianxia Wu; Afonso C Silva; Luca Massacesi; Steven Jacobson; Susan Westmoreland; Daniel S Reich
Journal:  Ann Neurol       Date:  2014-08-21       Impact factor: 10.422

Review 4.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

5.  Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple Sclerosis.

Authors:  Maxime Donadieu; Hannah Kelly; Diego Szczupak; Jing-Ping Lin; Yeajin Song; Cecil C C Yen; Frank Q Ye; Hadar Kolb; Joseph R Guy; Erin S Beck; Steven Jacobson; Afonso C Silva; Pascal Sati; Daniel S Reich
Journal:  Cereb Cortex       Date:  2021-01-01       Impact factor: 5.357

Review 6.  Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?

Authors:  Peter Göttle; Patrick Küry
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

Review 7.  Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?

Authors:  Jae Young Lee; Kasra Taghian; Steven Petratos
Journal:  Acta Neuropathol Commun       Date:  2014-08-27       Impact factor: 7.801

8.  Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.

Authors:  Mohsen Abbasi-Kangevari; Seyyed-Hadi Ghamari; Fahimeh Safaeinejad; Soheyl Bahrami; Hassan Niknejad
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.